#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Microvillous inclusion disease Becker's muscular dystrophy Paroxysmal nocturnal haemoglobinuria Infertility male Colon cancer Ewing's sarcoma metastatic C3 glomerulopathy Gaucher's disease type III Cystic fibrosis respiratory infection suppression Pseudomyxoma peritonei Haemophilia B without inhibitors Laryngeal squamous cell carcinoma Corneal neovascularisation Fibrous dysplasia of bone Measles More trials…

    Learn about Rare Diseases

    Friedreich’s ataxia Mitochondrial myopathy – Treatment Glomerulonephritis membranoproliferative – Life with Disease X-linked lymphoproliferative syndrome Gaucher’s disease type III – Life with Disease Wolfram syndrome – Basic Information Congenital generalised lipodystrophy – Trials in Disease Hereditary optic atrophy Langerhans cell sarcoma Atypical haemolytic uraemic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nicotine Resinate Viltolarsen S230815-2 Belantamab Mafodotin Triptorelin Acetate Pbf-999 Olanzapine Benzyl Alcohol Azd8630 Carboplatin Ddcart‐Cd19 Telitacicept Autogene Cevumeran VIPOGLANSTAT Cl-Ad-Msc-002 Cart45Ra-Nkg2D Cells Hydroxocobalamin Sodium Hyaluronate Ciltacabtagene Autoleucel Df1001 More therapies…

    Learn about Your Condition

    Cognitive disorder Decreased appetite Eye inflammation Neuralgia Sciatica Ataxia telangiectasia Adenosquamous cell lung cancer Niemann-Pick disease Psychological trauma Gastrointestinal melanoma Hepatobiliary cancer Breast cancer Femur fracture Aphthous ulcer Polymyositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Erythema migrans

  • Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Saccharomyces Boulardii Cncm I-745 Lyophilized
    • Amoxicillin
    Czechia Lithuania Slovakia Slovenia

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!